Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Current Deferred Revenue (2024 - 2025)

Incannex Healthcare's Current Deferred Revenue history spans 2 years, with the latest figure at $30000.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 11.11% to $30000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $30000.0, a 11.11% increase, with the full-year FY2025 number at $30000.0, down 64.71% from a year prior.
  • Current Deferred Revenue hit $30000.0 in Q4 2025 for Incannex Healthcare, roughly flat from $30000.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for IXHL hit a ceiling of $85000.0 in Q2 2024 and a floor of $27000.0 in Q4 2024.